Selected to lead the commercialization of Managed Market Resources (MMR), a managed markets consulting company, offering the pharmaceutical and biotechnology industry innovative solutions for the complex US healthcare industry. Responsible company growth and leading our teams in strategic support, new product launch development, market research and analytics, as well as educational programs specific to the market access segment for our clients. • Actively work with a network of prominent opinion leaders, industry experts, and key decision-makers within managed markets to create solutions for our clients• Develop customized customer centric strategies and tactics to create innovative solution plans for our clients that are practical and realistic in order to be executed• Selected by Rutgers Center for Management Development to develop and deliver programs as well as serve as an instructor for healthcare related topics.

Chosen to lead this endeavor called Biologics, a new area of strategic focus for Pfizer, and the campaign to address the declining small molecule market which they were so heavily leveraged in. Managed 4 different businesses: Multiple Sclerosis, Endocrine Care, Hemophilia and led Puerto Rico as General Manager.• Achieved over $1.2 Billion in Sales.• Finished 2009 at 106% of sales goal, with greater growth in 2010 at 107% of plan, highlighted by 20% growth in PR in 2009 and 22% in 2010.• General Manager of Puerto Rico with full P&L responsibility including Sales, Marketing, and Managed Markets for Specialty Care, Oncology, Vaccines, Anti-infections, Ophthalmics & Psychology markets.

Selected to turnaround the Endocrine care business to reverse declining sales and resolve compliance issues. Accountable for US ophthalmic and endocrine sale organizations with approximately $1 Billion in annual sales. Provided strategic direction for future business opportunities and sales/marketing in US and WW markets. Directed a sales team of 200 colleagues in exceeding sales goals for 4 straight years.• Launched Macugen® attaining 138% of sales goal or $185+ Million in launch year with a co-promote partner achieving 10 Pharma launches since 1995.• Developed and executed strategic plans to sustain Xalatan®’s 12 year dominate position in the US.• Built and maintained strong relationships with KOLs and thought leading Academic Institutions.• Retained 98% of US Pharmacia sales team and successfully inculcated to Pfizer.

Expanded role to assume the US Surgical Marketing Team in addition to leading both the US pharmaceutical and surgical sales forces with 235 employees and 11 direct reports generating over $550 Million in sales. Provided strategic direction for future sales development, medical education, reimbursement, federal government and managed care areas.• Designed and executed plan that increased the pharmaceutical sales force by over 50% in 4 month time period.• Critical team member that negotiated and sold Medical Surgical Device business to AMO.

Promoted and relocated to lead newly organized US ophthalmic sales for both medical device and pharmaceutical products. Built a lean, award-winning national sales force starting with 82 reps in 1987 to a maximum of 162 reps in 2001 with 15 sales managers. Provided strategic direction for future sales development, medical education, reimbursement, federal government and managed care areas for all products.• Grew sales growth to over $300 Million in the 4 year period. Consistently exceeded stretch sales goal in ’98, ’99, ’00 & ’01 with double digit EBIT growth posted each year.• Initiated plans in partnership with Marketing to create educational-based tool kit designed to establish a strong collaborative scientific relationship with physicians. Created a logo and branded field sales force which continued to grow the pride, culture, and high caliber of the team.• Key member of Xalatan® life cycle management team working with EU sales force design, launch goals and implementation. Achieved number one prescribed ophthalmic product in the US first full year on the market.

Senior management position with responsibility for sales operations generating $112+ Million in sales for all Pharmacia and Upjohn pharmaceutical products including Oncology, Women’s Health Care, and Ophthalmics. Directed a sales force of 108 employees with 13 direct reports. Closely interacting with corporate support functions implementing the corporate marketing plans. Heavy demands in recruitment and hiring of new representatives.

Responsible for sales of ophthalmic products generating $65 Million in sales. Directed a national sales force of 52 with 9 direct reports. Developed first national managed care performance contract with major national purchasing organization.

OR-Based Ophthalmic Capital Equipment sales; finished in the top 10%.